AOD-9604 research guide for Ati. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
AOD-9604 isn't available on pharmacy shelves in Ati or virtually any local market — it's a research compound distributed through a dedicated online market. What this means for Ati researchers is that geography is secondary to your ability to assess COA data — and those evaluation tools are within reach of all serious researchers. Vendors worth sourcing from make readily available batch-matched Certificates of Analysis containing HPLC purity analysis, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the specific lot you are purchasing. This guide guides Ati researchers through that evaluation process and explains what quality documentation for AOD-9604 should look like.
How AOD-9604 Works — Mechanisms & Research
AOD-9604 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Ati studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
AOD-9604 Purchasing Guide
Assessing AOD-9604 vendors requires starting from the COA: request the batch-specific certificate before placing an order, not after. A COA for AOD-9604 should include: HPLC purity percentage with the actual chromatogram data, mass spectrometry data establishing the correct molecular weight, endotoxin test results, and a residual solvent panel — all traceable to your batch. For Ati researchers evaluating new suppliers: a modest first purchase to test the product before committing to research quantities is what experienced peptide researchers consistently do. Bacteriostatic water is the correct reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 30 days refrigerated.
Order AOD-9604 — ships to Ati
COA-verified · International tracking · Research grade
AOD-9604 operates beyond the scope of approved drug regulation — researchers should understand that the known safety profile is based on preclinical evidence rather than regulated clinical data. Proper handling of AOD-9604 requires careful sterile procedure — prep pad-cleaned septum, single-use needles, uncontaminated workspace — and cold chain maintenance from receipt through use. Bacterial endotoxin contamination is the most serious safety risk associated with research-grade peptides — verify endotoxin testing is documented in your batch COA before any injectable research application. For any individual considering AOD-9604 outside a formal research context: speak with a healthcare professional — this compound is not approved for human use and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
